Webcast Goldman Sachs Global HC Conference, June 12 2019, 11:20 a.m. PT, Palos Verder

Discovery programs

Using our SIMPLE Antibody™ technology, we have created libraries of specific antibodies against multiple and diverse targets of therapeutic relevance.

We continue to focus on novel, complex targets with functional involvement in cancer and severe autoimmune diseases.